SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 191.75+1.0%Jan 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: J Stone who wrote (26587)11/18/1998 10:11:00 AM
From: Machaon   of 32384
 
<< We really don't want anymore hype from LGND about the pipeline. >>

Yes we do. But we want significant developments and discoveries rather than hype.

Reason: LGND's above average market value is based more on their pipeline and partnerships, rather than on Panretin Gel and Ontak. These two products represent initially small markets.

OTOH, if I am not mistaken, Panretin Gel represents the FIRST topical treatment for a skin cancer. That, to me, is a big first step.

Anyway, with 37 +/- products in the pipeline there is a high probability that we could see more frequent news going into the near future.

I'd still like to hear something about their Phase II Diabetes II Targretin clinical tests, in progress since March 1997. That is a big market.

Regards, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext